The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aerovate Therapeutics, Inc. | Common Stock | 008064107 | 56,894 | 3,103,879 | SH | SOLE | 3,103,879 | 0 | 0 | ||
| Akero Therapeutics, Inc. | Common Stock | 00973Y108 | 31,676 | 2,232,251 | SH | SOLE | 2,232,251 | 0 | 0 | ||
| AvroBio, Inc. | Common Stock | 05455M100 | 5,968 | 4,520,863 | SH | SOLE | 4,520,863 | 0 | 0 | ||
| Cogent Biosciences, Inc. | Common Stock | 19240Q201 | 1,397 | 186,487 | SH | SOLE | 186,487 | 0 | 0 | ||
| Day One Biopharmaceuticals, Inc. | Common Stock | 23954D109 | 81,360 | 8,201,638 | SH | SOLE | 8,201,638 | 0 | 0 | ||
| Dyne Therapeutics, Inc. | Common Stock | 26818M108 | 86,132 | 8,934,902 | SH | SOLE | 8,934,902 | 0 | 0 | ||
| F-star Therapeutics, Inc. | Common Stock | 30315R107 | 2,128 | 599,524 | SH | SOLE | 599,524 | 0 | 0 | ||
| Gemini Therapeutics, Inc. | Common Stock | 36870G105 | 7,304 | 5,254,365 | SH | SOLE | 5,254,365 | 0 | 0 | ||
| Generation Bio, Co. | Common Stock | 37148K100 | 60,767 | 8,278,876 | SH | SOLE | 8,278,876 | 0 | 0 | ||
| Ikena Oncology, Inc. | Common Stock | 45175G108 | 30,611 | 5,018,178 | SH | SOLE | 5,018,178 | 0 | 0 | ||
| Kymera Therapeutics, Inc. | Common Stock | 501575104 | 290,980 | 6,875,698 | SH | SOLE | 6,875,698 | 0 | 0 | ||
| Magenta Therapeutics, Inc. | Common Stock | 55910K108 | 10,082 | 3,476,536 | SH | SOLE | 3,476,536 | 0 | 0 | ||
| Replimune Group, Inc. | Common Stock | 76029N106 | 54,499 | 3,209,627 | SH | SOLE | 3,209,627 | 0 | 0 | ||
| Spero Therapeutics, Inc. | Common Stock | 84833T103 | 8,971 | 1,031,160 | SH | SOLE | 1,031,160 | 0 | 0 | ||
| Vigil Neuroscience, Inc. | Common Stock | 92673K108 | 41,033 | 5,836,874 | SH | SOLE | 5,836,874 | 0 | 0 | ||
| Viridian Therapeutics, Inc. | Common Stock | 92790C104 | 1,665 | 90,072 | SH | SOLE | 90,072 | 0 | 0 | ||
| Xilio Therapeutics, Inc. | Common Stock | 98422T100 | 19,509 | 2,759,344 | SH | SOLE | 2,759,344 | 0 | 0 | ||